Development of peptide epoxyketones as selective immunoproteasome inhibitors
- 1 October 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 221, 113556
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province Natural Science Foundation
This publication has 24 references indexed in Scilit:
- The Immunoproteasome as a Target in Hematologic MalignanciesSeminars in Hematology, 2012
- Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor SpecificityCell, 2012
- Immunoproteasomes2012
- PR‐924, a selective inhibitor of the immunoproteasome subunit LMP‐7, blocks multiple myeloma cell growth both in vitro and in vivoBritish Journal of Haematology, 2010
- Thymoproteasome Shapes Immunocompetent Repertoire of CD8+ T CellsImmunity, 2010
- Regulation of CD8 + T Cell Development by Thymus-Specific ProteasomesScience, 2007
- United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior TherapyClinical Cancer Research, 2006
- The 26S Proteasome: A Molecular Machine Designed for Controlled ProteolysisAnnual Review of Biochemistry, 1999
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å ResolutionScience, 1995